Notably, it was reported that the steroidal glycoalkaloids could inhibit the activity of acetylcholinesterase (Sucha & Tomsik, 2016), while the acetylcholinesterase-inhibitory activity of solasonine and its antitumor mechanism in NSCLC is still unclear. This evidence concerns the gene ACHE and non-small cell lung carcinoma.